1. Home
  2. RGEN vs TECH Comparison

RGEN vs TECH Comparison

Compare RGEN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • TECH
  • Stock Information
  • Founded
  • RGEN 1981
  • TECH 1976
  • Country
  • RGEN United States
  • TECH United States
  • Employees
  • RGEN N/A
  • TECH N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RGEN Health Care
  • TECH Health Care
  • Exchange
  • RGEN Nasdaq
  • TECH Nasdaq
  • Market Cap
  • RGEN 8.0B
  • TECH 7.9B
  • IPO Year
  • RGEN N/A
  • TECH 1989
  • Fundamental
  • Price
  • RGEN $131.55
  • TECH $51.61
  • Analyst Decision
  • RGEN Buy
  • TECH Buy
  • Analyst Count
  • RGEN 12
  • TECH 10
  • Target Price
  • RGEN $172.67
  • TECH $73.44
  • AVG Volume (30 Days)
  • RGEN 847.4K
  • TECH 2.3M
  • Earning Date
  • RGEN 04-29-2025
  • TECH 05-07-2025
  • Dividend Yield
  • RGEN N/A
  • TECH 0.62%
  • EPS Growth
  • RGEN N/A
  • TECH N/A
  • EPS
  • RGEN N/A
  • TECH 0.83
  • Revenue
  • RGEN $650,429,000.00
  • TECH $1,208,770,000.00
  • Revenue This Year
  • RGEN $13.93
  • TECH $8.19
  • Revenue Next Year
  • RGEN $14.35
  • TECH $8.61
  • P/E Ratio
  • RGEN N/A
  • TECH $62.17
  • Revenue Growth
  • RGEN 4.88
  • TECH 4.72
  • 52 Week Low
  • RGEN $102.97
  • TECH $46.44
  • 52 Week High
  • RGEN $182.52
  • TECH $85.57
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 47.85
  • TECH 49.54
  • Support Level
  • RGEN $123.10
  • TECH $46.77
  • Resistance Level
  • RGEN $143.56
  • TECH $54.40
  • Average True Range (ATR)
  • RGEN 6.82
  • TECH 2.03
  • MACD
  • RGEN -0.65
  • TECH 0.70
  • Stochastic Oscillator
  • RGEN 33.43
  • TECH 63.43

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: